Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trimmed logit method for estimating the ED50 in quantal bioassay.

L P Sanathanan1, E T Gade, N L Shipkowitz

  • 1Abbott Laboratories, North Chicago, Illinois 60064.

Biometrics
|December 1, 1987
PubMed
Summary

A new trimmed logit method improves quantal bioassay analysis by combining parametric and trimming advantages. This approach enhances the estimation of median effective dose (ED50) and other dose-response percentiles, especially with heavy-tailed data.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clarithromycin therapy of experimental Treponema pallidum infections in hamsters.

Antimicrobial agents and chemotherapy·1993
Same author

The randomized concentration-controlled trial: an evaluation of its sample size efficiency.

Controlled clinical trials·1991
Same author

In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile.

Antimicrobial agents and chemotherapy·1991
Same author

In vitro activity and in vivo efficacy of a new series of 9-deoxo-12-deoxy-9,12-epoxyerythromycin A derivatives.

Antimicrobial agents and chemotherapy·1991
Same author

Activity of temafloxacin against respiratory pathogens.

Antimicrobial agents and chemotherapy·1991
Same author

Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans.

Antimicrobial agents and chemotherapy·1990

Area of Science:

  • Biostatistics
  • Pharmacology
  • Toxicology

Background:

  • Traditional probit and logit models have limitations in analyzing quantal bioassay data.
  • Nonparametric methods like trimmed Spearman-Karber can be insufficient for calculating median effective dose (ED50).
  • Parametric models are useful for estimating various dose-response curve percentiles (e.g., ED10, ED25).

Purpose of the Study:

  • To introduce a novel trimmed logit method for quantal bioassay analysis.
  • To combine the benefits of parametric modeling with trimming for heavy-tailed distributions.
  • To provide a robust method for estimating ED50 and other dose-response percentiles.

Main Methods:

  • Development of a trimmed logit statistical model.
  • Application of the method to actual bioassay data sets.

Related Experiment Videos

  • Simulation studies to validate the trimmed logit method's performance.

    • Main Results:

    • The trimmed logit method successfully estimates ED50 when nonparametric methods fail.
    • The method effectively handles heavy-tailed distributions common in bioassays.
    • Simulation results confirm the validity and reliability of the trimmed logit approach.

    Conclusions:

    • The trimmed logit method offers a superior alternative for quantal bioassay analysis.
    • It provides accurate estimation of ED50 and other critical dose-response metrics.
    • A computer program is available for calculating ED50 and confidence intervals using this method.